Rockville, Oct. 24, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global EPA and DHA omega-3 ingredient market is increasing at a CAGR of 7.2% and is likely to reach a value of US $6.13 Bn by the end of 2033.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are special kinds of healthy fats found in fatty fish like salmon and in some algae. These are important as they help hearts work better, and even help with good moods. What makes EPA and DHA stand out is that human bodies can use them easily, which isn't the case for some other kinds of healthy fats. Moreover, these also do a great job of fighting inflammation, which is linked to many serious health issues. Plus, DHA is super important for babies' brains as they grow.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4050
The growth of the EPA and DHA omega-3 ingredient market is primarily driven by increasing consumer awareness about the health benefits associated with these fatty acids. As people become more health-conscious, rising demand for products promoting heart health and cognitive function is expected.
However, the market faces various challenges such as adding healthy ingredients to food without changing its taste or smell is a tough task for the manufacturers.
| Report Attribute | Details |
| Value Projection (2033) | US$ 6.13 Billion |
| Growth Rate (2023-2033) | 7.2% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 95 Tables |
| No. of Figures | 79 Figures |
Key Takeaways:
- The United States market is experiencing healthy growth due to an increasing health-conscious consumer base and positive regulatory support.
- Pharmaceutical channels are playing a major role in Fish-oil-based nutrient supplement sales.
- The Japanese market is expected to witness high sales due to the high aging population and emphasis on healthy aging in the country.
Increasing consumer awareness of health benefits, growing demand for functional foods, and emphasis on healthy aging seeking are the key factors driving the market growth - Says FACTMR Expert
Key Companies Profiled in This Report:
- KD Pharma Group
- The Archer Daniels Midland Company
- Corbion NV
- Novasep Holding SAS
- Neptune Wellness Solutions
- BASF SE
- Clover Corporation Ltd
- Croda International Plc
- Novotech Nutraceuticals
- Omega Protein Corporation
- Cargill Inc.
- Epax Norway AS
- GC Rieber Oils AS
- Pharma Marine AS
- Copeinca ASA
Market Competition
In this highly competitive market, the success of top companies hinges on their strategic marketing efforts, which play a pivotal role in determining their fate.
- In 2018, KD Pharma Group introduced two of its DHA and EPA Omega-3 ingredients designed for various uses, spanning from food and drinks to dietary supplements, infant nutrition, and animal feed.
- In June 2021, Polaris presented Omegavie DHA 800 Sensory Qualitysilver 5, a high-potency microalgae-derived DHA ingredient. Sourced from Schizochytrium sp., this algae oil is abundant in proteins, pigments, vitamins, and enzymes.
Winning strategies
- Developing omega-3 supplements with very high levels of EPA and DHA is a strong strategy in the EPA and DHA omega-3 market. This is because EPA and DHA offer proven health benefits, especially for heart and brain health.
- It's wise for companies to invest in algal-based supplements due to the growing popularity of plant-based diets. These supplements, sourced from microalgae, cater to the rising demand for vegetarian and vegan-friendly options.
- The top players should create omega-3 products that align with medical nutrition and dietary guidelines. They should focus on tailoring these products to meet the specific needs of individuals with different health conditions, such as heart health or cognitive function.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4050
Country-wise Analysis:
What factors are affecting the US market for EPA and DHA omega-3 supplements?
Large Base of Health-Conscious Consumers and Favorable Regulatory Support
As Americans become more health conscious, the market for EPA and DHA omega-3 components is expanding in a positive way. The demand for supplements and foods that have been enhanced with omega-3 fatty acids is rising as more Americans become aware of their health benefits.
The EPA and DHA omega-3 consumption in food or supplements may lower the risk of coronary heart disease and hypertension, according to qualified health claims that were approved by the US FDA on June 19, 2019.
Omega-3 health claims, particularly those relating to EPA and DHA, have also been approved by the US Food and Drug Administration (FDA) and can now be used in marketing and labeling. Its regulatory backing is boosting consumer confidence and boosting sales of EPA and DHA omega-3-based products.
Explore More Related Studies Published by Fact.MR Research:
Functional Dairy Ingredients Market: The global functional dairy ingredients market accounts for a revenue of US$ 201.47 billion in 2022 and is anticipated to surge to a market valuation of US$ 417.16 billion by the end of 2032.
Egg Replacement Ingredients Market: Expanding at a CAGR of 5.8%, the global egg replacement ingredients market is expected to increase from a valuation of US$ 1.2 billion in 2023 to US$ 2.1 billion by 2033-end.
Prebiotic Ingredients Market: Prebiotic ingredients market is expected to grow at a CAGR of 10.5% during the forecast period.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
